Uncover key drivers, emerging technologies, and competitive movements shaping the pharmaceutical contract development and manufacturing organization (cmo) market from 2025–2034 with trusted insights from The Business Research Company
How Will The Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Size Evolve Between Now And 2029?
The pharmaceutical contract development and manufacturing organization (CMO) market size has shown substantial growth in recent years. It is anticipated to increase from $174.33 billion in 2024 to $184.39 billion in 2025, achieving a compound annual growth rate (CAGR) of 5.8%. The expansion witnessed in the past can be linked to robust economic development in emerging markets, greater healthcare spending, an uplift in pharmaceutical research and development (R&D) expenditure, and a growing tendency for outsourcing.
The pharmaceutical contract development and manufacturing organization (CMO) market size is anticipated to expand significantly in the coming years. This market is projected to reach $255.58 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 8.5%. The expansion during the projected timeframe stems from factors such as heightened government backing, improved access to healthcare services, a rise in investments, and advancements in biopharmaceutical development. Key developments anticipated in this period encompass a greater emphasis on sustainability, the integration of artificial intelligence and digitalization, the introduction of innovative products prioritizing resilience, and a surge in investments and strategic alliances among industry participants.
Access A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2825&type=smp
Which Key Drivers Are Powering Growth In The Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market?
The growth of the pharmaceutical contract development and manufacturing market is driven by an escalating global demand for medicines. The high prevalence of illnesses and the pursuit of extended lifespans have amplified the need for medicines, prompting pharmaceutical firms to increase the production of existing drugs and enhance their R&D investments to facilitate the development of new drugs. This situation compels pharmaceutical companies to form partnerships with contract manufacturing organizations (CMOs) as a means to lower operational costs, thereby increasing the demand for the pharmaceutical contract development and manufacturing market. Alkermes PLC., a biopharmaceutical company, suggests that pharmaceutical contract manufacturing will become a strategic option for a wide array of companies, from very large corporations to smaller specialty pharma entities, largely because pharmaceutical companies are prioritizing cost-cutting.
How Is The Global Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Structured By Key Segments?
The pharmaceutical contract development and manufacturing organization (cmo) market covered in this report is segmented –
1) By Type: Contract Manufacturing Services, Contract Research Services
2) By Research Phase: Preclinical, Phase I, Phase II, Phase III, Phase IV
2) By End User: Big Pharmaceutical Companies, Generic Pharmaceutical Companies, Small And Medium-Sized Pharmaceutical Companies
Subsegments:
1) By Contract Manufacturing Services: Active Pharmaceutical Ingredient (API) Manufacturing, Formulation Development, Finished Dosage Form Manufacturing, Packaging Services, Supply Chain Management
2) By Contract Research Services: Preclinical Research Services, Clinical Trial Management, Regulatory Affairs Consulting, Biostatistics And Data Management, Analytical And Testing Services
What Future-Focused Trends Are Anticipated In The Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market?
Companies within the pharmaceutical contract development and manufacturing market are dedicating resources to acquiring and partnering with other entities in the sector. These Pharmaceutical contract development and manufacturing firms are pursuing mergers and acquisitions to extend their global market presence to meet client requirements, boost their production capabilities while maintaining cost-effectiveness, and gain access to advanced technology and new offerings. The considerable volume of merger and acquisition activities is leading to a greater consolidation among contract service providers. For example, in July 2022, Pharma Nobis, a US-based firm providing contract manufacturing and private label services, purchased Fagron’s U.S. contract manufacturing operation for an undisclosed amount. As a result of this acquisition, Pharma Nobis is anticipated to deliver contract manufacturing and private label services to American retailers and consumer healthcare corporations. Fagron will continue to hold a 20% stake in the company.
Which Companies Hold A Competitive Edge In The Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market?
Major companies operating in the pharmaceutical contract development and manufacturing organization (CMO) market include Lonza Group, Catalent Inc, WuXi AppTec Inc., Pfizer Inc, Recipharm AB, Almac Group, Aenova Group, Baxter International Inc, SGS Life Science Services SA, Jubilant Pharmova Ltd, Dishman Pharmaceuticals, Kemwell Pvt. Ltd., Nipro Corp., CMIC Group, Sawai Pharmaceutical Co., Ltd, IDT Australia Limited, Aurigene Pharmaceutical Services Limited, Vetter Pharma International GMBH, Consort Medical PLC, Siegfried Holding AG, Evonik Industries, NextPharma, Royal DSM N.V, HAUPT Pharma AG, Boehringer Ingelheim International GmbH, Famar, OTC-PharmNEUCA, Farmacol, Polska Grupa Farmaceutyczna, Polpharma, TZMO, AbbVie Inc, Merck & Co Inc, Amgen Inc, Gilead Sciences Inc, Regeneron Pharmaceuticals Inc, Vertex Pharmaceuticals Inc, Johnson & Johnson, Eurofarma Laboratórios S.A., Ache Laboratórios Farmacêuticos S.A., Blanver Farmoquímica e Farmacêutica S.A., Prati-Donaduzzi, União Química Farmacêutica Nacional S.A, Laboratorios Richmond S.A.C.I.F., Bago S.A., Elea Laboratories S.A.C.I. y F., Gador S.A., LIFEPharma, Neopharm, Gulf Pharmaceutical Industries JULPHA, NewBridge Pharmaceuticals Limited, Aspen Pharmacare Holdings Limited, Adcock Ingram Holdings Limited, Pharma-Q (Pty) Ltd, Vital Health Foods, EIPICO (Egyptian International Pharmaceutical Industries Company), Pharco Pharmaceuticals
Download The Full Report Here:
Which Region Is Expected To Lead The Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market In The Next Few Years?
North America was the largest region in the global pharmaceutical contract development and manufacturing market in 2024. The Middle East is expected to be the fastest-growing region in the global pharmaceutical contract development and manufacturing market during the forecast period. The regions covered in the pharmaceutical contract development and manufacturing organization (cmo) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Get A Report Customized For You Here:
https://www.thebusinessresearchcompany.com/customise?id=2825&type=smp
Browse Through More Reports Similar to the Global Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market 2025, By The Business Research Company
Pharmaceutical Sterility Testings Global Market Report 2025
Pharmaceutical Drugs Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/pharmaceutical-drugs-global-market-report
Pharmaceutical Excipient Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/pharmaceutical-excipient-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model